Two years after its $26-million purchase of Genomic Solutions, Harvard Bioscience said last week that it can align the unit profitably with its operations.

“We believe we have taken the necessary steps to return Genomic Solutions to profitability on its current run rate of revenues,” Chane Graziano, the Holliston, Mass.-based company’s CEO, said in a conference call with analysts last week. “The worst is behind us.”

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.